Global mapping of pharmacological space

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Nature Biotechnology

• Publication date

  2006-07-01

• Fields of study

  Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1038/nbt1228PMID 16841068
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Playing Dirty

  2007cited by this paper
• Kinomics: characterizing the therapeutically validated kinase space.

  2005cited by this paper
• CO: A chemical ontology for identification of functional groups and semantic comparison of small molecules

  2005cited by this paper
• Using Extended-Connectivity Fingerprints with Laplacian-Modified Bayesian Analysis in High-Throughput Screening Follow-Up

  2005cited by this paper
• Drug discovery: Playing dirty

  2005cited by this paper
• Ligand efficiency: a useful metric for lead selection.

  2004cited by this paper
• Selective optimization of side activities: another way for drug discovery.

  2004cited by this paper
• Navigating chemical space for biology and medicine

  2004cited by this paper
• Classification of kinase inhibitors using a Bayesian model.

  2004cited by this paper
• Annotating and mining the ligand-target chemogenomics knowledge space

  2004cited by this paper
• Kinomics-structural biology and chemogenomics of kinase inhibitors and targets.

  2004cited by this paper
• Molecular properties that influence oral drug-like behavior.

  2004cited by this paper
• NIH Molecular Libraries Initiative

  2004cited by this paper
• DataBase Systems: A Practical Approach to Design, Implementation and Management (4th Edition) (International Computer Science)

  2004cited by this paper
• Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia

  2004cited by this paper
• Characteristic physical properties and structural fragments of marketed oral drugs.

  2004cited by this paper
• Cytoscape: a software environment for integrated models of biomolecular interaction networks.

  2003cited by this paper
• Selection criteria for drug‐like compounds

  2003cited by this paper
• A specific mechanism of nonspecific inhibition.

  2003cited by this paper
• Biological mechanism profiling using an annotated compound library.

  2003cited by this paper
• A comparison of physiochemical property profiles of development and marketed oral drugs.

  2003cited by this paper
• Examination of the computed molecular properties of compounds selected for clinical development.

  2003cited by this paper
• Mining the NCI screening database: explorations of agents involved in cell cycle regulation.

  2003cited by this paper
• Prioritizing the human genome: knowledge management for drug discovery.

  2003cited by this paper
• Neighborhood Behavior of in Silico Structural Spaces with Respect to in Vitro Activity Spaces-A Novel Understanding of the Molecular Similarity Principle in the Context of Multiple Receptor Binding Profiles

  2003cited by this paper
• From Knowing to Controlling: A Path from Genomics to Drugs Using Small Molecule Probes

  2003influential reference
• Predicting ADME properties and side effects: the BioPrint approach.

  2003cited by this paper
• Handbook of Data Mining and Knowledge Discovery

  2002cited by this paper
• Guiding molecules towards drug-likeness.

  2002cited by this paper
• Molecular properties that influence the oral bioavailability of drug candidates.

  2002cited by this paper
• An Ontology for Pharmaceutical Ligands and Its Application for in Silico Screening and Library Design

  2002cited by this paper
• Prediction of 'drug-likeness'.

  2002cited by this paper
• Guiding molecules towards drug-likeness.

  2002cited by this paper
• The druggable genome

  2002cited by this paper
• Drugs, leads, and drug-likeness: an analysis of some recently launched drugs.

  2002cited by this paper
• Simple selection criteria for drug-like chemical matter.

  2001cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

  2001cited by this paper
• Computational methods to estimate drug development parameters.

  2001cited by this paper
• Drug-like properties and the causes of poor solubility and poor permeability.

  2000cited by this paper
• Chemical genetics: ligand-based discovery of gene function

  2000cited by this paper
• The Multiplicity of Serotonin Receptors: Uselessly Diverse Molecules or an Embarrassment of Riches?

  2000cited by this paper
• The maximal affinity of ligands.

  1999cited by this paper
• Structure-activity relationship homology (SARAH): a conceptual framework for drug discovery in the genomic era.

  1999cited by this paper
• Toward designing drug-like libraries: a novel computational approach for prediction of drug feasibility of compounds.

  1999cited by this paper
• Recognizing molecules with drug-like properties.

  1999cited by this paper
• Can we learn to distinguish between "drug-like" and "nondrug-like" molecules?

  1998cited by this paper
• The role of innovation in drug development.

  1997cited by this paper
• Classic drug targets

  1997cited by this paper
• Drug Development: The role of innovation in drug development

  1997cited by this paper
• An Information-Intensive Approach to the Molecular Pharmacology of Cancer

  1997cited by this paper
• Genomic sciences and the medicine of tomorrow

  1996cited by this paper
• Drug prototypes and their exploitation

  1996cited by this paper
• Knowledge Discovery in Databases

  1991cited by this paper
• Thirty‐three years of drug discovery and research with Dr. Paul Janssen

  1986cited by this paper
• Functional group contributions to drug-receptor interactions.

  1984cited by this paper

• KRDQN: An Interpretable Prediction Framework for Adverse Drug Reactions via Knowledge–Graph Reinforced Deep Q-Learning

  2026cites this paper
• Enzymes in secondary pharmacology screening panels: is there room for improvement?

  2025cites this paper
• Network-Based Approaches for Drug Target Identification.

  2025cites this paper
• AI-Driven Polypharmacology in Small-Molecule Drug Discovery

  2025cites this paper
• Structure-based discovery and conformational analysis of non-phosphomimetic bidentate inhibitor for protein tyrosine phosphatase 1B.

  2025cites this paper
• Network‐based precision medicine and systems pharmacology

  2025cites this paper
• Drug repurposing through pathway perturbation dynamics: A systems biology approach for precision oncology

  2025cites this paper
• Meta-analysis and review of in silico methods in drug discovery – part 1: technological evolution and trends from big data to chemical space

  2025cites this paper
• Crystallographic Ensembles Reveal the Structural Basis of Binding Entropy in SARS-CoV2 Macrodomain

  2025cites this paper
• Artificial Intelligence Models and Tools for the Assessment of Drug–Herb Interactions

  2025cites this paper
• Time‐evolved metrics for safety pharmacological assessments of small molecules and biologics

  2025cites this paper
• Network pharmacology to elucidate the role of phytotherapy in neurocognitive disorders.

  2025cites this paper
• Genome-wide CRISPR screening identifies CLDN1 as a central node in the anticancer mechanisms of berberine and as a therapeutic target in lung cancer

  2025cites this paper
• Testing the predictive power of reverse screening to infer drug targets, with the help of machine learning

  2024cites this paper
• Targeting the peripheral neural-tumour microenvironment for cancer therapy

  2024cites this paper
• Global and regional genetic association analysis of ulcerative colitis and type 2 diabetes mellitus and causal validation analysis of two-sample two-way Mendelian randomization

  2024cites this paper
• Revolutionizing drug discovery: The impact of artificial intelligence on advancements in pharmacology and the pharmaceutical industry

  2024cites this paper
• Medicinal polypharmacology—a scientific glossary of terminology and concepts

  2024influential citation
• Integrated Thermal Proteome Profiling and Affinity Ultrafiltration Mass Spectrometry (iTPAUMS): A Novel Paradigm for Elucidating the Mechanism of Action of Natural Products.

  2024cites this paper
• Transforming Pharmacological Research: Utilizing AI and Machine Learning in Drug Discovery and Development

  2024cites this paper
• Data-oriented protein kinase drug discovery.

  2024cites this paper
• Quantifying Cancer Drug Targetability across Biochemical Pathways

  2024cites this paper
• Polypharmacology prediction: the long road toward comprehensively anticipating small-molecule selectivity to de-risk drug discovery

  2024cites this paper
• Spaces of mathematical chemistry

  2024cites this paper
• Remapping the Chemical Space and the Pharmacological Space of Drugs: What Can We Expect from the Road Ahead?

  2024cites this paper
• The Current Landscape in the Development of Small-molecule Modulators Targeting Sphingosine-1-phosphate Receptors to Treat Neurodegenerative Diseases.

  2024cites this paper
• Bioinformatics Approaches in the Development of Antifungal Therapeutics and Vaccines

  2024cites this paper
• DeepARV: ensemble deep learning to predict drug-drug interaction of clinical relevance with antiretroviral therapy

  2024cites this paper
• The state of the art in secondary pharmacology and its impact on the safety of new medicines

  2024cites this paper
• Comprehensive Data-Driven Assessment of Non-Kinase Targets of Inhibitors of the Human Kinome

  2024cites this paper
• Origins and progression of the polypharmacology concept in drug discovery

  2024cites this paper
• Self-reinforcing Mechanisms Driving the Evolution of the Chemical Space

  2023cites this paper
• Integrating population-level and cell-based signatures for drug repositioning

  2023cites this paper
• Artificial Intelligence for Drug Discovery: Are We There Yet?

  2023cites this paper
• Medicinal polypharmacology: Exploration and exploitation of the polypharmacolome in modern drug development

  2023cites this paper
• Using network pharmacology to fabricate crosslinked hyaluronan–chondroitin sulphate-resveratrol composite hydrogels for cartilage regeneration

  2023cites this paper
• In silico Strategy: A Promising Implement in the Development of Multitarget Drugs against Neurodegenerative Diseases.

  2023cites this paper
• Metabolic, toxicological, chemical, and commercial perspectives on esterification of dietary polyphenols: a review

  2023cites this paper
• Self-reinforcing Mechanisms Driving the Evolution of the Chemical Space

  2023cites this paper
• Opportunities and challenges in application of artificial intelligence in pharmacology

  2023cites this paper
• Towards a more inductive world for drug repurposing approaches

  2023cites this paper
• A novel in silico scaffold-hopping method for drug repositioning in rare and intractable diseases

  2023cites this paper
• A novel strategy for designing the magic shotguns for distantly related target pairs

  2023cites this paper
• Breaking Barriers: Current Advances and Future Directions in Mpox Therapy.

  2023cites this paper
• Comparative Therapeutic Approaches for Hepatocellular Carcinoma-A Concise Review

  2023cites this paper
• Weapons and Strategies against COVID-19: A Perspective.

  2023cites this paper
• Mannosylated Gold Nanoclusters Incorporated with a Repurposed Antihistamine Drug Promethazine for Antibacterial and Antibiofilm Applications.

  2022cites this paper
• Drug Repositioning in Response to COVID-19 and other Challenging Diseases

  2022cites this paper
• Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment

  2022cites this paper
• Combined In Silico and In Vitro Evidence Supporting an Aurora A Kinase Inhibitory Role of the Anti-Viral Drug Rilpivirine and an Anti-Proliferative Influence on Cancer Cells

  2022cites this paper
• High-resolution view of compound promiscuity [version 2; peer review: 3 approved]

  2022cites this paper
• A Computational Pipeline to Identify and Characterize Binding Sites and Interacting Chemotypes in SARS-CoV-2

  2022cites this paper
• Mechanism of Glycitein in the Treatment of Colon Cancer Based on Network Pharmacology and Molecular Docking

  2022cites this paper
• Unmodified methodologies in target discovery for small molecule drugs: A rising star

  2022cites this paper
• Approaches for enhancing the analysis of chemical space for drug discovery

  2022cites this paper
• Comprehensive review on repurposing of approved medicine in the management of COVID-19 infection

  2022cites this paper
• The emerging role of mass spectrometry-based proteomics in drug discovery

  2022cites this paper
• How fullerene derivatives (FDs) act on therapeutically important targets associated with diabetic diseases

  2022cites this paper
• Contexts and contradictions: a roadmap for computational drug repurposing with knowledge inference

  2022cites this paper
• Zearalenone damages the male reproductive system of rats by destroying testicular focal adhesion

  2022cites this paper
• Pharmacological Target Engagement and Validation

  2021cites this paper
• The Strategy of Studying the Herb-Pair Inter-Reinforcement Mechanism Mapping on Chemical Space Between Sparganii Rhizoma and Curcumae Rhizoma

  2021cites this paper
• Out-of-the-box deep learning prediction of pharmaceutical properties by broadly learned knowledge-based molecular representations

  2021cites this paper
• Artificial intelligence to deep learning: machine intelligence approach for drug discovery

  2021cites this paper
• Toward an Understanding of Pan-Assay Interference Compounds and Promiscuity: A Structural Perspective on Binding Modes

  2021cites this paper
• Milk-Way Algorithm applied in Imbalanced Dataset

  2021cites this paper
• COVID-19 Multi-Targeted Drug Repurposing Using Few-Shot Learning

  2021cites this paper
• Conformational Strain of Macrocyclic Peptides in Ligand-Receptor Complexes Based on Advanced Refinement of Bound-State Conformers.

  2021cites this paper
• Modern Tools and Techniques in Computer-Aided Drug Design

  2021cites this paper
• Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer's Disease Therapy

  2021cites this paper
• Natural product drug discovery in the artificial intelligence era

  2021cites this paper
• Development of a chemogenomics library for phenotypic screening

  2021cites this paper
• Drug repurposing strategies and key challenges for COVID-19 management

  2021cites this paper
• Set-Theoretic Formalism for Treating Ligand-Target Datasets

  2021cites this paper
• Magic Rings: Navigation in the Ring Chemical Space Guided by the Bioactive Rings

  2021cites this paper
• Repurposing Cardio-Metabolic Drugs to Fight Covid19

  2021cites this paper
• Computational Prediction of Chemical Tools for Identification and Validation of Synthetic Lethal Interaction Networks.

  2021cites this paper
• Connecting chemistry and biology through molecular descriptors.

  2021cites this paper
• Approaches for network based drug discovery.

  2021cites this paper
• A COMPREHENSIVE REVIEW ON PHARMACEUTICAL AND NUTRITIONAL APPLICATIONS OF INULIN

  2021cites this paper
• Advances in Nucleoside and Nucleotide Analogues in Tackling Human Immunodeficiency Virus and Hepatitis Virus Infections

  2021cites this paper
• Network Analysis, and Experimental Validation to Uncover the Mechanism of the Four Compounds in Artemisia annua (Qing Hao) Antimalarial

  2020cites this paper
• Chemogenomics and bioinformatics approaches for prioritizing kinases as drug targets for neglected tropical diseases.

  2020cites this paper
• Daurichromenic Acid from the Chinese Traditional Medicinal Plant Rhododendron dauricum Inhibits Sphingomyelin Synthase and Aβ Aggregation

  2020cites this paper
• Evolution of kinase polypharmacology across HSP90 drug discovery

  2020cites this paper
• DeepH-DTA: Deep Learning for Predicting Drug-Target Interactions: A Case Study of COVID-19 Drug Repurposing

  2020cites this paper
• Identifying representative kinases for inhibitor evaluation via systematic analysis of compound-based target relationships.

  2020cites this paper
• Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer′s Disease Therapy

  2020cites this paper
• Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling.

  2020influential citation
• The activities of drug inactive ingredients on biological targets

  2020cites this paper
• Improved Multitask Learning in Neural Networks for Predicting Selective Compounds

  2020cites this paper
• A practical guide to secondary pharmacology in drug discovery.

  2020cites this paper
• Drug repurposing approach to fight COVID-19

  2020cites this paper
• Drug Research Meets Network Science: Where Are We?

  2020cites this paper
• Drug design targeting active posttranslational modification protein isoforms

  2020cites this paper
• Turning liabilities into opportunities: Off-target based drug repurposing in cancer.

  2020cites this paper
• The kinase polypharmacology landscape of clinical PARP inhibitors

  2020cites this paper
• Discovery of a Gut-Restricted JAK Inhibitor for the Treatment of Inflammatory Bowel Disease.

  2020cites this paper
• 3-Quinuclidinyl-α-methoxydiphenylacetate: a multi-targeted ligand with antimuscarinic and antinicotinic effects designed for the treatment of anticholinesterase poisoning.

  2020cites this paper
• Predicting commercially available antiviral drugs that may act on the novel coronavirus (2019-nCoV), Wuhan, China through a drug-target interaction deep learning model

  2020cites this paper